We are live on
!
Find out more
FP
Factorial Partners Portfolio holdings
AUM
$138M
1-Year Est. Return
25.59%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+25.59%
3 Year Est. Return
+78.35%
5 Year Est. Return
+78.52%
10 Year Est. Return
–
AUM
$145M
AUM Growth
+$12.1M
(+9.1%)
Cap. Flow
-$209K
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
30.01%
Holding
96
New
10
Increased
20
Reduced
30
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dine Brands
DIN
|
+$1.47M |
| 2 |
Gilead Sciences
GILD
|
+$1.12M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$1.08M |
| 4 |
Perrigo
PRGO
|
+$973K |
| 5 |
UnitedHealth
UNH
|
+$958K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$1.63M |
| 2 |
Gates Industrial Corporation Ltd.
GTES
|
+$1.14M |
| 3 |
iShares Russell 2000 Value ETF
IWN
|
+$1.08M |
| 4 |
AutoNation
AN
|
+$791K |
| 5 |
TPH
Tri Pointe Homes
TPH
|
+$662K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 22.25% |
| 2 | Financials | 22.23% |
| 3 | Industrials | 19.75% |
| 4 | Healthcare | 14.89% |
| 5 | Technology | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Phibro Animal Health
PAHC
$1.42B
| $1.13M | 0.78% |
82,200
+3,500
| +4% | +$50.1K |
|
|
52
Invesco S&P 500 Equal Weight ETF
RSP
$96.9B
| $1.12M | 0.77% |
+7,500
| New | +$1.08M |
|
53
Cheesecake Factory
CAKE
$4.26B
| $1.11M | 0.76% |
32,000
| – | – |
|
|
54
Gilead Sciences
GILD
$164B
| $1.08M | 0.74% |
+14,000
| New | +$1.12M |
|
55
Vitesse Energy
VTS
$637M
| $1.08M | 0.74% |
48,000
+1,000
| +2% | +$20.9K |
|
56
B&G Foods
BGS
$291M
| $1.02M | 0.7% |
73,300
-22,000
| -23% | -$317K |
|
57
Franklin Resources
BEN
$17.3B
| $954K | 0.66% |
35,700
| – | – |
|
58
Asbury Automotive
ABG
$4.24B
| $950K | 0.66% |
+3,950
| New | +$831K |
|
59
Post Holdings
POST
$4.16B
| $867K | 0.6% |
10,000
-2,450
| -20% | -$215K |
|
60
AngioDynamics
ANGO
$575M
| $808K | 0.56% |
+77,500
| New | +$746K |
|
61
Macy's
M
$6.5B
| $803K | 0.55% |
50,000
| – | – |
|
62
Fortune Brands Innovations
FBIN
$6.15B
| $791K | 0.55% |
11,000
-3,500
| -24% | -$223K |
|
63
Orthofix Medical
OFIX
$472M
| $761K | 0.53% |
42,154
-3,300
| -7% | -$61.6K |
|
64
OraSure Technologies
OSUR
$277M
| $741K | 0.51% |
148,000
-21,000
| -12% | -$126K |
|
|
EBIX
65
DELISTED
Ebix Inc
EBIX
| $731K | 0.5% |
29,000
+7,100
| +32% | +$133K |
|
66
Enact Holdings
ACT
$6.6B
| $729K | 0.5% |
+29,000
| New | +$707K |
|
67
NCR Voyix
VYX
$1.13B
| $711K | 0.49% |
45,966
-1,630
| -3% | -$23.5K |
|
68
Xperi
XPER
$371M
| $684K | 0.47% |
52,000
+21,000
| +68% | +$228K |
|
69
Inogen
INGN
$172M
| $590K | 0.41% |
51,100
-7,500
| -13% | -$88.4K |
|
70
Organon & Co
OGN
$3.56B
| $583K | 0.4% |
28,000
-19,500
| -41% | -$424K |
|
71
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$1.35B
| $576K | 0.4% |
7,000
| – | – |
|
72
American Express
AXP
$228B
| $557K | 0.38% |
3,200
| – | – |
|
73
First Horizon
FHN
$12.2B
| $496K | 0.34% |
+44,000
| New | +$590K |
|
74
BJ's Restaurants
BJRI
$1.42B
| $487K | 0.34% |
15,300
| – | – |
|
75
CRA International
CRAI
$1.12B
| $466K | 0.32% |
4,567
| – | – |
|
Similar funds
TC
PBRA
DFS
LPAM
CI
ACA
LIA
CW
Factorial Partners's Q2 2023 Portfolio in Review
As of Q2 2023, Factorial Partners held 96 positions worth $145M, up 9.1% from $133M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Factorial Partners's Q2 2023 filing shows 10 new, 20 increased, 30 reduced and 7 closed positions. Its largest new stake was Dine Brands: 23,000 shares worth $1.33M. The largest sale was Biogen, an estimated $1.63M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Factorial Partners's largest Q2 2023 buy was Dine Brands: 23,000 shares worth $1.33M.
- Factorial Partners added most to Perrigo in Q2 2023, an estimated $973K increase.
- Factorial Partners's biggest Q2 2023 reduction was iShares Russell 2000 Value ETF, cutting an estimated $1.08M.
- Factorial Partners fully exited Biogen in Q2 2023, selling an estimated $1.63M.
- Factorial Partners's ten largest holdings make up 30% of its $145M portfolio in Q2 2023.
- Factorial Partners opened 10 new positions and closed 7 in Q2 2023.
- Factorial Partners's portfolio value rose 9.1% quarter-over-quarter to $145M.
Based on Factorial Partners's 13F filing for Q2 2023, filed 2 Aug 2023.